Jane Adams
Jane Adams is a neurodevelopmental toxicologist whose research focuses on the consequences of prenatal exposure to certain prescription medications as well as other agents. Her current research focuses primarily on the effects upon child neuropsychological development following in utero exposure to antiepileptic drugs. Her research has been supported by the National Institutes of Child Health and Development, the National Alliance for Autism Research, the March of Dimes, and Pfizer, Inc. Dr. Adams serves as Editor-in-Chief of the journal, Neurotoxicology and Teratology. She has served as a Past President of the Neurobehavioral Teratology Society and has held multiple elected positions in this society as well as in the Teratology Society. Dr. Adams teaches Behavioral Neuroscience (Psy 260), Psychopharmacology (Psy 362), Neurotoxicology (Psy 490), and Pharmacotherapy for Mental Health Disorders (Psy 662).
Selected Publications
Hines, RN, Adams, J, Buck, GM, Faber, W, et al. NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Fluoxetine. Birth Defects Research Part B: Reproductive and Developmental Toxicology, 71:193-280, 2004.
Adams, J, Janulewicz, PA, and Gavin, JA. The Structural and Functional Teratology of Antiepileptic Medications. In: Human Developmental Neurotoxicology, D. Bellinger (ed), Taylor and Francis, New York, p 103-131, 2006.
Office: McCormack, 4th floor, Rm 270
Telephone: 617-287-6347
Email: jane.adams@umb.edu
Office Hours: W 12:00-2:00, TH 3:30-4:30